Vaxart, Inc. Patent Applications Rejected
3 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2017-09-22: Application 15713289; Invention ANHYDROUS CRYSTALLINE FREE BASE FORM OF 6-{2-[1-(6-METHYL-3-PYRIDAZINYL)-4-PIPERIDINYL]ETHOXY}-3-ETHOXY-1,2-BENZISOXAZOLE; Applicant VAXART, INC.; Status Abandoned -- Failure to Respond to an Office Action.
- 2017-04-07: Application 15517768; Invention HSV VACCINES; Applicant Vaxart, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2016-08-18: Application 15120069; Invention FORMULATIONS FOR SMALL INTESTINAL DELIVERY; Applicant Vaxart, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2017-09-22 | 15713289 | ANHYDROUS CRYSTALLINE FREE BASE FORM OF 6-{2-[1-(6-METHYL-3-PYRIDAZINYL)-4-PIPERIDINYL]ETHOXY}-3-ETHOXY-1,2-BENZISOXAZOLE | VAXART, INC. | Abandoned -- Failure to Respond to an Office Action | US20180162849A1 | Edward LEE David MCALLISTER Andrew TRIGWELL Robert Vincent TUOHY III Peter SNYDER JR. Christa Leisa FRASSETTO | United States Australia Australia United States United States United States | RAO, SAVITHA M |
| 2017-04-07 | 15517768 | HSV VACCINES | Vaxart, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170298389A1 | Ciaran Scallan Wendy Peters | United States United States | GILL, RACHEL B |
| 2016-08-18 | 15120069 | FORMULATIONS FOR SMALL INTESTINAL DELIVERY | Vaxart, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170224805A1 | Sean Tucker George Trager | United States United States | PROSSER, ALISSA J |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |